(Q39892918)

15 September 2017

title

Microtubule-damaging agents enhance RASSF1A-induced cell death in lung cancer cell lines (English)

1 reference

15 September 2017

5

Yeul Hong Kim

1 reference

15 September 2017

Young Mi Whang

1

1 reference

15 September 2017

Kyong Hwa Park

series ordinal

2

1 reference

15 September 2017

Hae-Yun Jung

series ordinal

3

1 reference

15 September 2017

Uk Hyun Jo

series ordinal

4

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 March 2009

1 reference

15 September 2017

number of pages

14

1 reference

inferred from page(s)

published in

Cancer

1 reference

15 September 2017

volume

115

1 reference

15 September 2017

issue

6

1 reference

15 September 2017

page(s)

1253-1266

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24113

15 September 2017

1 reference

7 January 2021

Cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24113

7 January 2021

Nationwide cancer incidence in Korea, 1999~2001; first result using the national cancer incidence database

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24113

7 January 2021

The risk of second primary tumors after resection of stage I nonsmall cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24113

7 January 2021

Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24113

7 January 2021

CpG island methylation and expression of tumour-associated genes in lung carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24113

7 January 2021

Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24113

7 January 2021

Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24113

7 January 2021

Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24113

7 January 2021

Control of microtubule stability by the RASSF1A tumor suppressor

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24113

7 January 2021

Specificity of the methylation-suppressed A isoform of candidate tumor suppressor RASSF1 for microtubule hyperstabilization is determined by cell death inducer C19ORF5

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24113

7 January 2021

Regulation of the MST1 kinase by autophosphorylation, by the growth inhibitory proteins, RASSF1 and NORE1, and by Ras

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24113

7 January 2021

The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC-Cdc20 complex

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24113

7 January 2021

The pro-apoptotic Ras effector Nore1 may serve as a Ras-regulated tumor suppressor in the lung

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24113

7 January 2021

The scaffold protein CNK1 interacts with the tumor suppressor RASSF1A and augments RASSF1A-induced cell death

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24113

7 January 2021

The tumor suppressor RASSF1A and MAP-1 link death receptor signaling to Bax conformational change and cell death

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24113

7 January 2021

The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24113

7 January 2021

RASSF1A suppresses the c-Jun-NH2-kinase pathway and inhibits cell cycle progression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24113

7 January 2021

Taxol stabilizes microtubules in mouse fibroblast cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24113

7 January 2021

Interaction of vinca alkaloids with tubulin: a comparison of vinblastine, vincristine, and vinorelbine

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24113

7 January 2021

State-of-the-art chemotherapy for advanced non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24113

7 January 2021

Microtubules as a target for anticancer drugs

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24113

7 January 2021

Tumor suppressor RASSF1A is a microtubule-binding protein that stabilizes microtubules and induces G2/M arrest

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24113

7 January 2021

Sequential dephosphorylation of p34(cdc2) on Thr-14 and Tyr-15 at the prophase/metaphase transition

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24113

7 January 2021

Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24113

7 January 2021

Taxane-platinum combinations in advanced non-small cell lung cancer: a review

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24113

7 January 2021

Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non--small-cell lung cancer: a Southwest Oncology Group trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24113

7 January 2021

Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24113

7 January 2021

The tumor suppressor RASSF1A does not interact with Cdc20, an activator of the anaphase-promoting complex

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24113

7 January 2021

Identifiers

DOI

10.1002/CNCR.24113

1 reference

15 September 2017

1 reference